Risk prediction of progression to multiple myeloma from MGUS or smoldering myeloma by multi-color flow cytometric analysis

Risk prediction of progression to multiple myeloma from MGUS or smoldering myeloma by multi-color flow cytometric analysis - MM-MFC2017

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031063

Enrollment

Registered

2018-02-01

Start date

2017-06-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MGUS, smoldering myeloma, and multiple myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with MGUS, smoldering multiple myeloma and untreated multiple myeloma whose clinical diagnosis is determined accurately using medical examination containing bone marrow puncture.

Exclusion criteria

Exclusion criteria: Exclusion criteria are not set up. However, patients who received anti-myeloma treatment are excluded.

Design outcomes

Primary

Measure	Time frame
We investigate the phenotype of BM plasma cells collected from patients with MGUS, smoldering multiple myeloma and multiple myeloma using multi-color flow cytometer, and analyze the difference by the type of the diseases.	—

Secondary

Measure	Time frame
We identify the markers to predict the risk of progression to multiple myeloma from MGUS and smoldering myeloma.	—

Countries

Japan

Contacts

Public ContactYasushi Takamatsu

Fukuoka University Faculty of Medicine Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine

yasushi@fukuoka-u.ac.jp092-801-1011

Outcome results